AlzChem Group (Germany) Performance
| ACT Stock | EUR 57.40 0.20 0.35% |
On a scale of 0 to 100, AlzChem Group holds a performance score of 13. The firm shows a Beta (market volatility) of 0.41, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AlzChem Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding AlzChem Group is expected to be smaller as well. Please check AlzChem Group's treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to make a quick decision on whether AlzChem Group's price patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AlzChem Group AG are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, AlzChem Group exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 17.1 M | |
| Free Cash Flow | 43 M |
AlzChem |
AlzChem Group Relative Risk vs. Return Landscape
If you would invest 4,150 in AlzChem Group AG on September 16, 2024 and sell it today you would earn a total of 1,590 from holding AlzChem Group AG or generate 38.31% return on investment over 90 days. AlzChem Group AG is generating 0.5427% of daily returns assuming 3.2084% volatility of returns over the 90 days investment horizon. Simply put, 28% of all stocks have less volatile historical return distribution than AlzChem Group, and 90% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
AlzChem Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AlzChem Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AlzChem Group AG, and traders can use it to determine the average amount a AlzChem Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1691
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ACT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.21 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.54 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average AlzChem Group is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AlzChem Group by adding it to a well-diversified portfolio.
AlzChem Group Fundamentals Growth
AlzChem Stock prices reflect investors' perceptions of the future prospects and financial health of AlzChem Group, and AlzChem Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AlzChem Stock performance.
| Current Valuation | 256.64 M | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 0.35 X | |||
| Revenue | 422.29 M | |||
| EBITDA | 62.69 M | |||
| Total Debt | 37.55 M | |||
| Cash Flow From Operations | 43.02 M | |||
| Total Asset | 377.67 M | |||
About AlzChem Group Performance
By analyzing AlzChem Group's fundamental ratios, stakeholders can gain valuable insights into AlzChem Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AlzChem Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AlzChem Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about AlzChem Group AG performance evaluation
Checking the ongoing alerts about AlzChem Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AlzChem Group AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AlzChem Group AG appears to be risky and price may revert if volatility continues |
- Analyzing AlzChem Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AlzChem Group's stock is overvalued or undervalued compared to its peers.
- Examining AlzChem Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AlzChem Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AlzChem Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AlzChem Group's stock. These opinions can provide insight into AlzChem Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AlzChem Stock analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |